Cytokinetics, Incorporated
Cytokinetics, Incorporated (CYTK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYTK · as of Jun 8, 2026
Key Statistics
Explore Cytokinetics, Incorporated Data
cytk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 35 · Buy rate: 94.3%
The CYTK analyst consensus is Buy, based on ratings from 35 Wall Street analysts over the past 3 months. The average 12-month price target is $99.92, representing +39.79% upside from the current price of $71.48.
Competitors & Peers
cytk competitorsCYTK
ABVX
AXSM
CORT
CRSP
HALOStock Performance
Full HistoryAbout Cytokinetics, Incorporated
Cytokinetics, Incorporated a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating di…
what is cytokinetics, incorporated · cytk stock overview · cytokinetics, incorporated company profile · who is cytokinetics, incorporated ceo · cytk NASDAQ · cytokinetics, incorporated headquarters · cytokinetics, incorporated business segments
About Stock Overview & Key Data
Cytokinetics, Incorporated (CYTK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 30, 2004. As of the latest trading session, CYTK stock price is $71.48, with a market capitalization of $8.9B. The stock has returned +115.76% over the past 12 months and +12.50% year-to-date.
According to 35 Wall Street analysts, the consensus rating for Cytokinetics, Incorporated stock is Buy, with an average 12-month price target of $99.92. In fiscal year 2025, Cytokinetics, Incorporated reported revenue of $88.0M and net income of -$785.0M. For detailed data — including Cytokinetics, Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cytokinetics, Incorporated (CYTK) stock price is $71.48. The stock is traded on NASDAQ under the ticker symbol CYTK. The 52-week range is $31.52 – $80.20.